Kodiak Sciences Inc. (KOD)
Healthcare • Biotechnology
StockNasdaqGMUnited StatesUS50015M1099
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Kodiak Sciences Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:35. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 12 Nov 2026 16:00 | -1.01 | -1.05 | -3.9% | Miss |
| 13 Aug 2026 16:00 | -0.96 | — | — | — |
| 07 May 2026 16:00 | -1.01 | -0.94 | +7.1% | Beat |
| 31 Mar 2026 16:00 | -1.05 | -1.04 | +1.3% | Beat |
| 13 Nov 2025 16:00 | -1.04 | -1.16 | -11.5% | Miss |
| 13 Aug 2025 16:00 | -1.05 | -1.03 | +1.6% | Beat |
| 14 May 2025 16:00 | -0.87 | -1.09 | -24.7% | Miss |
| 27 Mar 2025 16:00 | -0.86 | -0.84 | +2.8% | Beat |
| 14 Nov 2024 16:00 | -0.90 | -0.84 | +6.6% | Beat |
| 14 Aug 2024 16:00 | -0.85 | -0.86 | -0.6% | In line |
| 15 May 2024 16:00 | -1.06 | -0.82 | +22.6% | Beat |
| 28 Mar 2024 06:00 | -0.75 | -1.13 | -50.2% | Miss |
| 14 Nov 2023 16:00 | -1.35 | -0.95 | +29.6% | Beat |
| 14 Aug 2023 16:00 | -1.15 | -1.53 | -33.3% | Miss |
| 15 May 2023 16:00 | -1.37 | -1.35 | +1.2% | Beat |
| 28 Mar 2023 16:00 | -1.49 | -1.35 | +9.6% | Beat |
| 09 Nov 2022 16:00 | -1.71 | -1.47 | +14.0% | Beat |
| 09 Aug 2022 16:00 | -1.74 | -1.74 | +0.1% | In line |
| 10 May 2022 16:00 | -1.56 | -1.83 | -17.7% | Miss |
| 01 Mar 2022 16:00 | -1.33 | -1.79 | -34.6% | Miss |
| 09 Nov 2021 16:00 | -1.18 | -1.30 | -10.6% | Miss |
| 09 Aug 2021 16:00 | -1.03 | -1.08 | -4.8% | Miss |
| 10 May 2021 05:00 | -0.98 | -0.98 | +0.3% | In line |
| 01 Mar 2021 05:00 | -0.71 | -0.97 | -37.3% | Miss |
| 09 Nov 2020 05:00 | -0.70 | -0.80 | -14.2% | Miss |
| 10 Aug 2020 05:00 | -0.57 | -0.58 | -2.6% | Miss |
| 11 May 2020 05:00 | -0.46 | -0.54 | -16.9% | Miss |
| 16 Mar 2020 05:00 | -0.31 | -0.40 | -28.5% | Miss |
| 12 Nov 2019 05:00 | -0.33 | -0.33 | 0.0% | In line |
| 14 Aug 2019 05:00 | -0.29 | -0.31 | -6.9% | Miss |
| 15 May 2019 06:00 | -0.37 | -0.21 | +42.7% | Beat |
| 28 Mar 2019 06:00 | -0.30 | -0.25 | +16.8% | Beat |
| 16 Nov 2018 16:00 | -0.26 | -0.38 | -46.2% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 0 | — | -230M | — | -4.32 | -29.0% | -136.5M |
| 2024 | 0 | — | -176.2M | — | -3.35 | +32.6% | -117.7M |
| 2023 | 0 | — | -260.5M | — | -4.97 | +22.2% | -195.6M |
| 2022 | 0 | — | -333.8M | — | -6.39 | — | -253.8M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 99.31 | 112.31 | 90.50 | 107.96 | +8.85% | 7,720,246 | |
| Oct 2026 | 95.41 | 104.00 | 79.06 | 99.18 | +4.62% | 32,158,600 | |
| Sep 2026 | 37.01 | 98.80 | 29.81 | 94.80 | +153.82% | 65,052,000 | |
| Aug 2026 | 41.67 | 46.87 | 35.50 | 37.35 | -10.17% | 12,485,900 | |
| Jul 2026 | 38.50 | 44.85 | 35.77 | 41.58 | +6.72% | 13,734,000 | |
| Jun 2026 | 35.82 | 39.39 | 29.21 | 38.96 | +6.13% | 19,048,900 | |
| May 2026 | 43.22 | 46.59 | 32.93 | 36.71 | -15.57% | 12,724,200 | |
| Apr 2026 | 39.78 | 47.84 | 38.22 | 43.48 | +14.06% | 18,758,900 | |
| Mar 2026 | 26.12 | 45.60 | 21.00 | 38.12 | +42.24% | 34,668,900 | |
| Feb 2026 | 23.06 | 28.85 | 20.88 | 26.80 | +17.70% | 12,814,200 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2026 Financial Results (opens in a new tab) 12 Nov 2026 21:00
- Kodiak Sciences to Present at Three Upcoming Investor Conferences (opens in a new tab) 11 Nov 2026 23:43
- Kodiak Sciences (KOD) Stock Looks At A Premium On Its Huge 3 Year Run (opens in a new tab) Simply Wall St. · 10 Nov 2026 02:10
- Can Zenkuda's Multi-Indication Potential Drive KOD Stock Higher? (opens in a new tab) Zacks · 19 Oct 2026 13:10
- Kodiak Sciences (KOD) Could Be 7% Overvalued Following Late Stage Data Update (opens in a new tab) Simply Wall St. · 08 Oct 2026 20:12
- Kodiak Sciences (KOD) Stock Trades At A Premium On DAYBREAK Trial News (opens in a new tab) Simply Wall St. · 08 Oct 2026 16:13
- Kodiak Sciences’ Two Wet AMD Treatments Match Aflibercept in Phase III Study (opens in a new tab) MarketBeat · 02 Oct 2026 19:02
- This week in charts: Kodiak’s big comeback and Hengrui’s dealmaking (opens in a new tab) BioPharma Dive · 02 Oct 2026 16:00
- Kodiak Sciences More Than Doubles on Eye Disease Trial Results (opens in a new tab) Barchart · 01 Oct 2026 15:57
- A $32 Biotech Became a $90 Biotech Overnight. Is It Too Late to Buy Kodiak? (opens in a new tab) 24/7 Wall St. · 30 Sep 2026 13:05
- KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing Nears (opens in a new tab) Zacks · 29 Sep 2026 15:13
- What Does Regeneron Pharmaceuticals (REGN) Need To Prove In Eye Disease Now? (opens in a new tab) Simply Wall St. · 29 Sep 2026 08:08
- Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs? (opens in a new tab) Stocktwits · 29 Sep 2026 05:23
- New Eye Treatment Boosts Kodiak Into Ranks of Resurgent Biotechs (opens in a new tab) The Daily Upside · 29 Sep 2026 05:01
- Why Kodiak Sciences Skyrocketed Today (opens in a new tab) Motley Fool · 29 Sep 2026 03:58
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 108.25 USD
- Market cap
- 6.8B
- Exchange
- NasdaqGM
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow KOD and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.